⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Official Title: A Phase IIIb Single Arm, Open-label, Multicentre Study of Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (SIERRA)

Study ID: NCT05883644

Study Description

Brief Summary: This study will assess the safety and efficacy of Single Tremelimumab Regular Interval Durvalumab (STRIDE) as first-line therapy in participants with advanced unresectable HCC.

Detailed Description: This is a Phase IIIb, open-label, single arm, multicentre study to assess the safety and efficacy of STRIDE as first-line therapy in participants with advanced unresectable HCC who have one of the following: 1. Child-Pugh score B7 or B8 with a World Health Organisation Eastern Cooperative Oncology Group Performance Status (WHO/ECOG PS) of 0-1 at enrolment, or 2. Child-Pugh class A with a WHO/ECOG PS of 2 at enrolment, or 3. Child-Pugh class A with a WHO/ECOG PS of 0-1 and with evidence of chronic main trunk portal vein thrombosis at enrolment Participants must not have received any prior systemic therapy for HCC. Participants may have previously received locoregional therapy (LRT) but must no longer be suitable for additional LRT. Any local treatment needs to have been completed at least 4 weeks prior to initiation of treatment. The study consists of 4 periods: screening (Day-28 to Day -1), Treatment period, safety follow-up and survival follow-up.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, La Jolla, California, United States

Research Site, Shreveport, Louisiana, United States

Research Site, Detroit, Michigan, United States

Research Site, Bobigny, , France

Research Site, Clichy, , France

Research Site, Creteil, , France

Research Site, Lyon, , France

Research Site, Marseille, , France

Research Site, Rennes, , France

Research Site, Berlin, , Germany

Research Site, Frankfurt, , Germany

Research Site, Köln, , Germany

Research Site, Lübeck, , Germany

Research Site, Magdeburg, , Germany

Research Site, Mannheim, , Germany

Research Site, Hong Kong, , Hong Kong

Research Site, Shatin, , Hong Kong

Research Site, Milano, , Italy

Research Site, Napoli, , Italy

Research Site, Padova, , Italy

Research Site, Pisa, , Italy

Research Site, Rozzano, , Italy

Research Site, Turin, , Italy

Research Site, Chiba-shi, , Japan

Research Site, Chuo-ku, , Japan

Research Site, Kanazawa-shi, , Japan

Research Site, Kashiwa, , Japan

Research Site, Kyoto-shi, , Japan

Research Site, Matsuyama-city, , Japan

Research Site, Musashino-shi, , Japan

Research Site, Osakasayama-shi, , Japan

Research Site, Yokohama-shi, , Japan

Research Site, Gyeonggi-do, , Korea, Republic of

Research Site, Seongnam-si, , Korea, Republic of

Research Site, Seoul, , Korea, Republic of

Research Site, Seoul, , Korea, Republic of

Research Site, Seoul, , Korea, Republic of

Research Site, Seoul, , Korea, Republic of

Research Site, Singapore, , Singapore

Research Site, Singapore, , Singapore

Research Site, Singapore, , Singapore

Research Site, Barcelona, , Spain

Research Site, Barcelona, , Spain

Research Site, Cordoba, , Spain

Research Site, Madrid, , Spain

Research Site, Madrid, , Spain

Research Site, Pamplona, , Spain

Research Site, Hanoi, , Vietnam

Research Site, Ho Chi Minh, , Vietnam

Contact Details

Name: Stephen Chan, MD

Affiliation: Department of Clinical Oncology, Chinese University of Hong Kong

Role: PRINCIPAL_INVESTIGATOR

Name: Lorenza Rimassa, MD

Affiliation: Humanitas Cancer Centre, IRCCS Humanitas Research Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: